Measuring Is the First Treatment
Most midlife care starts with a guess — a symptom, a supplement, a prescription, and a hope. We start with numbers. Comprehensive labs, hormone and metabolic panels, and targeted diagnostics that tell a clinician what is actually happening before anything is prescribed.
Testing is available on its own. You are not obligated to begin treatment, and if your numbers say you do not need something, we will tell you that.
We measure first. Then we act.
Why we measure first
“Low energy” is not a diagnosis. It is a symptom that could trace to thyroid function, iron, testosterone, sleep architecture, blood glucose, or none of those. Treating the symptom without knowing which one is the reason so much midlife care produces a shelf of half-finished bottles and no change.
A baseline turns that guesswork into a decision. It tells your clinician where you actually are, what is worth addressing first, and — just as usefully — what you can stop worrying about. It also gives you something to measure against later, so progress is a number rather than an impression.
This is the part of the model that does not change. Whatever you come to us for, it starts here.
What we test
Offered to eligible patients. Most people begin with the Comprehensive Lab Panel and add targeted panels only where their history or baseline results point that way.
Comprehensive Lab Panel
A comprehensive blood panel establishing your baseline across key health markers.
View treatmentDUTCH® Test
An advanced dried-urine panel mapping hormones and their metabolites.
View treatmentContinuous Glucose Monitor
A continuous glucose monitor prescription for real-time glucose data.
View treatmentMethylation Health Panel
A panel assessing the methylation pathway and its B-vitamin cofactors.
View treatmentGut Biome Analysis
A microbiome analysis profiling your gut bacteria to inform your plan.
View treatmentGI Effects + Microbiomix
An expanded gut panel pairing comprehensive stool analysis with deeper microbiome sequencing.
View treatmentGalleri® Multi-Cancer Early Detection Test
Lab-developed testA GRAIL laboratory-developed blood test that screens for a shared cancer signal across many cancer types.
View treatmentTests marked Lab-developed test are performed by a single CLIA-certified laboratory and have not been cleared or approved by the FDA. They are intended to add to, not replace, recommended screening.
What happens with your results
A results portal on its own is not care. A clinician reads your panel with you, explains what each marker means in the context of your history, and tells you plainly what is worth acting on and what is not. Sometimes the honest answer is that nothing needs prescribing yet — and that is a legitimate outcome, not a failed appointment.
The baseline behind every plan
Testing is the entry point to the rest of the model, not a separate product line. Whichever direction your results point, the plan is built from them.
How it works at ACT 2 Health
Testing is step one of five, and it is the step the other four depend on. See the full model.
- 01
Measure
A baseline of labs and history, and a clear read on what you're trying to improve.
- 02
Plan
A clinician reads your results with you and decides what to address first.
- 03
Act
If treatment is appropriate, you begin with clear guidance and support.
- 04
Track
We retest on a defined cadence rather than guessing at progress.
- 05
Adjust
Plans are refined against the next set of numbers, not against how you felt that week.
Frequently asked questions
In almost every case, yes. A clinician cannot responsibly build a plan around hormones, metabolic health or peptides without knowing your starting numbers. Testing is what makes the rest of the plan specific to you rather than generic.
Yes. Testing is offered on its own, and there is no obligation to start any treatment afterwards. Some patients come to us purely for a thorough baseline and a clinician's read on it.
The Comprehensive Lab Panel is the usual starting point and covers the broadest set of markers. The more targeted panels — hormones, gut, methylation, glucose — are typically added when your history or your baseline results point that way. A clinician helps you choose.
Laboratory testing is regulated differently from medication. Most panels are run by CLIA-certified laboratories under that framework rather than through FDA approval. The Galleri test is a laboratory-developed test from GRAIL and has not been cleared or approved by the FDA; it is intended to add to, not replace, recommended cancer screening.
No. Testing is available to eligible patients as a starting point, and it is often how people begin before deciding whether ongoing care fits them.
It depends on what we are tracking and whether you have started treatment. Your clinician sets a cadence at the point of planning so retesting is deliberate rather than reactive.
Start with the numbers
A baseline is the shortest route to a plan that fits you — and the only honest way to know whether you need one at all.
We measure first. Then we act.
Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.
ACT 2 Health provides clinician-led care. Testing and treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination. This page is educational and is not medical advice. Individual results vary.